Interventions to Improve Daily Activity in Heart Failure
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02331524|
Recruitment Status : Completed
First Posted : January 6, 2015
Last Update Posted : February 23, 2017
|Condition or disease||Intervention/treatment||Phase|
|Heart Failure||Behavioral: Activity Feedback and Encouragement Other: Health Coaching/Home Exercise||Not Applicable|
Few studies have been able to demonstrate intervention efficacy for improving daily activity in heart failure (HF). Exercise alone is ineffective, though psychosocial-based interventions including health coaching and daily activity feedback appear to be promising. Therefore, the primary purpose of the present proposed study is to investigate the effect of two different intervention approaches (1. daily activity feedback with associated encouragement, and 2. health coaching with an associated individualized home exercise program) on daily activity, exercise tolerance, HF-related health status, and lower extremity functional strength. A secondary purpose is to compare daily activity as recorded by Medtronic® implanted cardioverter defibrillator (ICDs) and cardiac resynchronization therapy (CRT) devices to daily activity recorded by a well-established triaxial accelerometer.
This will be a single-blinded randomized trial, with subject randomization stratified by age and baseline activity level. Subjects will be randomized to one of three groups: 1) A control group receiving usual care, 2) a group receiving only feedback with associated encouragement about their daily activity, and 3) an intervention group that will receive health coaching with an associated individualized home exercise program.
The study will consist of a 3 month intervention period and a 6 month follow-up/ retention period (total study enrollment period of 9 months). The primary study endpoint is Medtronic device-measured daily activity. All study endpoints will be assessed at baseline, 3 months, and 9 months. The investigators who are conducting study measurements will be blinded to group assignment.
Using a previously established minimum clinically important difference (MCID) of 1.08 hours per day for improvement in daily activity (effect size=1.54) as measured by Medtronic ICDs/CRTs, a total of 8 subjects per group would be needed to achieve a statistical power (1-β) of 0.80 (two-tailed, α=0.05) for a between-groups comparison utilizing two groups. Therefore, depending on the observed effect size in the proposed study, utilizing 3 groups with approximately 10 subjects in each group should provide adequate statistical power for a between-groups comparison with 3 groups.
Statistical analyses will be conducted to meet the planned study objectives. With regard to intervention effects, one way analysis of variance with planned contrasts will be used to examine between-group differences for each of the continuous variables [Patient Activity, Kansas City Cardiomyopathy Questionnaire (KCCQ), Patient Health Questionnaire (PHQ-9), six-minute walk test (6MWT), 30 second timed chair rise (30-s TCR), heart rate variability, Optivol Fluid Index]. If the data do not meet the requisite assumptions, the Kruskal-Wallis analysis of variance by ranks will be used. Baseline to 3 months data will be used to assess immediate intervention effects and to 9 month follow-up will be used to assess retention effects.
With regard to concurrent validity of the Medtronic Patient Activity measurement, the Pearson correlation coefficient will be calculated between the daily Patient Activity (minutes per day) and two Actigraph parameters: daily activity count and steps per day. Correlation coefficients will be calculated for the baseline, 3-month, and 9-month monitoring periods to provide a greater number of sampling days. Correlation coefficients will also be calculated for changes in daily activity measurements between baseline and 3 months and baseline and 9 months to determine concurrent validity of change in daily activity measurements.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||16 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Exercise and Psychosocial-Based Interventions to Improve Daily Activity in Heart Failure|
|Study Start Date :||October 2014|
|Actual Primary Completion Date :||July 2016|
|Actual Study Completion Date :||July 2016|
No Intervention: Control/Usual Care
Usual care only
Experimental: Activity Feedback and Encouragement
Weekly Feedback about daily activity using the FitBit Zip
Behavioral: Activity Feedback and Encouragement
The Daily Activity Feedback/ Encouragement group will receive weekly feedback and encouragement regarding daily activity using the Fitbit Zip® for 3 months. Visual feedback and verbal encouragement will be provided. Visual feedback will provide graphics showing current and historical daily activity trends since the start of the intervention period. Subjects in the Feedback group will also receive standardized verbal feedback based upon the Fitbit Zip data. For example, subjects demonstrating a trend of increasing daily activity will be encouraged to "Continue what you are doing. You are doing great!"
Experimental: Health Coaching/Home Exercise
Weekly contact from physical therapist to develop and progress home exercise program and by health coach for goal setting and support
Other: Health Coaching/Home Exercise
The Health Coaching/Home Exercise group will receive 12 weekly health coaching and physical therapy visits for 3 months. Health coaching will be provided by a trained, highly experienced health and wellness coach. In-home health coaching sessions will be provided monthly (total of 3) with the remaining 9 sessions provided telephonically. Initial health coaching sessions will include the utilization of motivational interviewing to establish individualized, three-month goals related to symptoms, function, and/or daily activity, with subsequent sessions celebrating successes in and/or identifying barriers to achieving these goals.
- Change in Medtronic Implanted Device Patient Activity Measure [ Time Frame: Change from baseline to 3 and 9 months ]
- Change in ActiGraph Daily Activity [ Time Frame: Change from baseline to 3 and 9 months ]
- Change in Six-Minute Walk Test [ Time Frame: Change from baseline to 3 and 9 months ]
- Change in 30 Second Timed Chair Rise [ Time Frame: Change from baseline to 3 and 9 months ]
- Change in Kansas City Cardiomyopathy Questionnaire [ Time Frame: Change from baseline to 3 and 9 months ]
- Change in 9 Item Patient Health Questionnaire [ Time Frame: Change from baseline to 3 and 9 months ]
- Change in Health Care Utilization [ Time Frame: Change from baseline to 3 and 9 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02331524
|United States, Michigan|
|Spectrum Health Heart and Lung Specialized Care Clinic|
|Grand Rapids, Michigan, United States, 49503|
|Principal Investigator:||Michael Shoemaker, DPT, PhD||Grand Valley State University|